Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

PM Justin Trudeau Visits Pfizer Vaccine Facility - Puurs

Pfizers Director Aseptic Manufacturing Koen Vastenavond gives a tour of a vaccine facility to Canadian Prime Minister Justin Trudeau, Belgium Prime Minister Alexander De Croo and Pfizer Managing Director Luc Van Steenwinkel on Tuesday June 15, 2021 in Puurs, Belgium. Photo by Adrian Wyld/CP/ABACAPRESS.COM

E

PM Justin Trudeau Visits Pfizer Vaccine Facility - Puurs

Canadian Prime Minister Justin Trudeau and Belgium Prime Minister Alexander De Croo, Pfizer Managing Director Luc Van Steenwinkel and Director Aseptic Manufacturing Koen Vastenavond tour a Pfizer vaccine facility Tuesday June 15, 2021 in Puurs, Belgium. Photo by Adrian Wyld/CP/ABACAPRESS.COM

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (3L) and Manager Director of Pfizer Puurs Luc Van Steenwinkel (2L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (C) and Manager Director of Pfizer Puurs, Luc Van Steenwinkel (R) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (3L) and Manager Director of Pfizer Puurs , Luc Van Steenwinkel (2L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel (not seen) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs

King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

King Philippe of Belgium (R) is welcomed by Manager Director of Pfizer Puurs Luc Van Steenwinkel (L) during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

King Philippe of Belgium (R) is welcomed by Manager Director of Pfizer Puurs Luc Van Steenwinkel (L) during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)

E

King Philippe Visits Pfizer-BioNTech - Belgium

King Philippe of Belgium (R) is welcomed by Manager Director of Pfizer Puurs Luc Van Steenwinkel (L) during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM (Credit:Reporters/ABACA/Kyodo News Images)